Evidence map›Paper›PMID 39417311›Full record

ArticleEuropean journal of neurology2025

Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke.

Alicia Sierra-Gómez, María Esther Ramos-Araque, Sven P R Luijten, Mercedes de Lera Alfonso, Ana Calleja, Gonzalo Valle-Peñacoba, Beatriz Gómez-Vicente, Javier Reyes, Mario Martínez-Galdámez, Jorge Galván and 4 more

Abstract read
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Systemic immune-inflammation index predicts hemorrhagic transformation after endovascular therapy for ischemic stroke.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alicia Sierra-GómezDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.ORCID 0000-0002-1939-2134
María Esther Ramos-AraqueDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
Sven P R LuijtenDepartment of Radiology and Nuclear Medicine, Erasmus MC, The Netherlands.
Mercedes de Lera AlfonsoDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
Ana CallejaDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
Gonzalo Valle-PeñacobaDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
Beatriz Gómez-VicenteDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
Javier ReyesDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.
Mario Martínez-GaldámezDepartment of Radiology and Nuclear Medicine, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid, Spain.
Jorge GalvánDepartment of Radiology and Nuclear Medicine, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid, Spain.
Miguel Schüller-ArteagaDepartment of Radiology and Nuclear Medicine, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid, Spain.
Lorenzo Pérez SánchezDepartment of Radiology and Nuclear Medicine, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid, Spain.
Daniel BosDepartment of Radiology and Nuclear Medicine, Erasmus MC, The Netherlands.ORCID 0000-0001-8979-2603
Juan F ArenillasDepartment of Neurology, Hospital Clínico Universitario de Valladolid (HCUV), Valladolid Health Research Institute, Valladolid, Spain.

Funding

Instituto de Salud Carlos III CM21/00163Instituto de Salud Carlos III JR19/00020Instituto de Salud Carlos III PI19-01398Instituto de Salud Carlos III RD21/0006/0005Instituto de Salud Carlos III RD21/0006/0020
6 · The paper itself

Abstract

background and purposeThe influence of intracranial arteriosclerosis (ICAR) on acute ischaemic stroke (AIS) prognosis is unclear. This study explored its impact, focusing on ICAR subtypes categorized by intracranial carotid artery calcification (ICAC) patterns: intimal or atherosclerotic versus internal elastic lamina calcification or non-atherosclerotic. The aim was to determine their effect on AIS prognosis in patients undergoing endovascular treatment (EVT).

methodsThis prospective cohort study included consecutive AIS patients with anterior circulation large vessel occlusion undergoing EVT. ICAC, the hallmark of ICAR, was assessed using non-contrast computed tomography to quantify volume and establish the predominant ICAR subtype. The primary outcome was long-term functional outcome, measured by the 90-day modified Rankin Scale score. Secondary outcomes included first-pass effect, revascularization degree, symptomatic intracranial haemorrhage and 24-h infarct volume. Multivariate-adjusted linear and logistic regression models were used to assess the association of ICAC volume and subtype with these outcomes.

resultsFrom January 2021 to February 2022, 181 patients were included, of whom 172 (95%) had ICAC. Internal elastic lamina calcification was the predominant subtype in 103 (57%), intimal in 52 (29%) and mixed in 17 (9%). The intimal or atherosclerotic ICAC pattern was linked to poorer functional outcomes (adjusted odds ratio 2.12, 95% confidence interval [CI] 1.10-4.09), decreased first-pass effect probability (adjusted odds ratio 0.42, 95% CI 0.21-0.84) and higher infarct volume (adjusted β value 22.11, 95% CI 0.55-43.67).

conclusionsA predominant intimal ICAC subtype, linked to underlying atherosclerosis, correlated with larger infarct volume and poorer 90-day functional outcomes in EVT-treated AIS patients. Intracranial atherosclerosis appears to be a relevant factor hampering clinical benefits post-EVT.

Indexed as

Endovascular ProceduresIntracranial ArteriosclerosisIschemic StrokeAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedPrognosisProspective StudiesVascular Calcificationacute ischaemic strokeendovascular treatmentinternal elastic lamina calcificationintimal calcificationintracranial arteriosclerosisintracranial atherosclerosisintracranial carotid artery calcification

Identifiers

PMID39417311
PMCPMC11622314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.